Vertex Pharmaceuticals (VRTX) Assets Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.93% |
| Dec 31, 2025 | 16.89% |
| Sep 30, 2025 | 17.08% |
| Jun 30, 2025 | 18.66% |
| Mar 31, 2025 | 20.80% |
| Dec 31, 2024 | 22.06% |
| Sep 30, 2024 | 24.24% |
| Jun 30, 2024 | 23.41% |
| Mar 31, 2024 | 29.59% |
| Dec 31, 2023 | 29.48% |
| Sep 30, 2023 | 36.29% |
| Jun 30, 2023 | 36.24% |
| Mar 31, 2023 | 36.85% |
| Dec 31, 2022 | 38.62% |
| Sep 30, 2022 | 39.18% |
| Jun 30, 2022 | 36.52% |
| Mar 31, 2022 | 37.07% |
| Dec 31, 2021 | 35.91% |
| Sep 30, 2021 | 37.05% |
| Jun 30, 2021 | 36.82% |
| Mar 31, 2021 | 37.25% |
| Dec 31, 2020 | 36.30% |
| Sep 30, 2020 | 35.95% |
| Jun 30, 2020 | 33.89% |
| Mar 31, 2020 | 32.64% |
| Dec 31, 2019 | 28.93% |
| Sep 30, 2019 | 25.58% |
| Jun 30, 2019 | 27.13% |
| Mar 31, 2019 | 24.39% |
| Dec 31, 2018 | 21.92% |
| Sep 30, 2018 | 12.34% |
| Jun 30, 2018 | 10.90% |
| Mar 31, 2018 | 10.57% |
| Dec 31, 2017 | 5.15% |
| Sep 30, 2017 | 3.30% |
| Jun 30, 2017 | 4.75% |
| Mar 31, 2017 | 4.67% |
| Dec 31, 2016 | 5.62% |
| Sep 30, 2016 | 4.52% |
| Mar 31, 2016 | 10.09% |
| Dec 31, 2015 | 7.69% |
| Sep 30, 2015 | 5.20% |
| Jun 30, 2015 | 7.49% |
| Mar 31, 2015 | 4.12% |
| Dec 31, 2014 | 3.61% |